Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Mari

Showing results (31-40 of 575) with videos related to

Pageof 58
Sort By:
European Urology Focus|January 1, 2021
Reply to Nikolaos Grivas, Sanchia Goonewardene, Wouter Everaerts, Nikolaos Kalampokis's Letter to the Editor re: Andrea Mari, Riccardo Tellini, Francesco Porpiglia, et al. Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2, Project). Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.07.004Andrea Mari, Riccardo Tellini, Vincenzo Ficarra, et al.
JCI Insight|December 21, 2018
Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescentsDomenico Tricò, Andrea Natali, Silva Arslanian, et al.
Diabetes, Obesity & Metabolism|March 8, 2022
Fixed-ratio combination of insulin glargine plus lixisenatide (iGlarLixi) improves ß-cell function in people with type 2 diabetesEle Ferrannini, Elisabeth Niemoeller, Terry Dex, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|February 3, 2018
RECORd1 project: what have we learned?Andrea Minervini, Andrea Mari, Vincenzo Ficarra, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2022
Loss of the Incretin Effect in Type 2 Diabetes: A Systematic Review and Meta-analysisEleonora Grespan, Annamaria Guolo, Elza Muscelli, et al.
The Journal of Clinical Endocrinology and Metabolism|January 24, 2024
Low-Dose Sulfonylurea Plus DPP4 Inhibitor Lower Blood Glucose and Enhance Beta-Cell Function Without HypoglycemiaRuth L M Cordiner, Khaled Bedair, Andrea Mari, et al.
Metabolism: Clinical and Experimental|November 2, 2020
Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetesEleonora Grespan, Toni Giorgino, Andrea Natali, et al.
Current Opinion in Urology|October 19, 2017
Novel endoscopic visualization techniques for bladder cancer detection: a review of the contemporary literatureAndrea Mari, Mohammad Abufaraj, Killian M Gust, et al.
Diabetologia|March 12, 2026
Beta cell glucose sensitivity identifies clinical response to disease-modifying therapies initiated at stage 3 type 1 diabetes onsetCarmella Evans-Molina, Stephen E Gitelman, Andrea Mari, et al.
The Journal of Urology|January 4, 2022
The Association between Income Status and Treatment Selection for Prostate Cancer in a Universal Health Care System: A Population-Based Analysis. LetterAntonio Andrea Grosso, Fabrizio Di Maida, Andrea Mari, et al.
Pageof 58

Showing results (31-40 of 575) with videos related to

Sort By:
Pageof 58
European Urology Focus|January 1, 2021
Reply to Nikolaos Grivas, Sanchia Goonewardene, Wouter Everaerts, Nikolaos Kalampokis's Letter to the Editor re: Andrea Mari, Riccardo Tellini, Francesco Porpiglia, et al. Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2, Project). Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.07.004Andrea Mari, Riccardo Tellini, Vincenzo Ficarra, et al.
JCI Insight|December 21, 2018
Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescentsDomenico Tricò, Andrea Natali, Silva Arslanian, et al.
Diabetes, Obesity & Metabolism|March 8, 2022
Fixed-ratio combination of insulin glargine plus lixisenatide (iGlarLixi) improves ß-cell function in people with type 2 diabetesEle Ferrannini, Elisabeth Niemoeller, Terry Dex, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|February 3, 2018
RECORd1 project: what have we learned?Andrea Minervini, Andrea Mari, Vincenzo Ficarra, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2022
Loss of the Incretin Effect in Type 2 Diabetes: A Systematic Review and Meta-analysisEleonora Grespan, Annamaria Guolo, Elza Muscelli, et al.
The Journal of Clinical Endocrinology and Metabolism|January 24, 2024
Low-Dose Sulfonylurea Plus DPP4 Inhibitor Lower Blood Glucose and Enhance Beta-Cell Function Without HypoglycemiaRuth L M Cordiner, Khaled Bedair, Andrea Mari, et al.
Metabolism: Clinical and Experimental|November 2, 2020
Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetesEleonora Grespan, Toni Giorgino, Andrea Natali, et al.
Current Opinion in Urology|October 19, 2017
Novel endoscopic visualization techniques for bladder cancer detection: a review of the contemporary literatureAndrea Mari, Mohammad Abufaraj, Killian M Gust, et al.
Diabetologia|March 12, 2026
Beta cell glucose sensitivity identifies clinical response to disease-modifying therapies initiated at stage 3 type 1 diabetes onsetCarmella Evans-Molina, Stephen E Gitelman, Andrea Mari, et al.
The Journal of Urology|January 4, 2022
The Association between Income Status and Treatment Selection for Prostate Cancer in a Universal Health Care System: A Population-Based Analysis. LetterAntonio Andrea Grosso, Fabrizio Di Maida, Andrea Mari, et al.
Pageof 58